Back
PNT
Panther Metals Ltd
🇦🇺 ASX
⛏️ MINING
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-26.18%
Annual Growth
4 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
1
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Panther Metals Ltd. focuses on identifying and acquiring prospective mineral exploration projects. The company is headquartered in Perth, Western Australia. The company went IPO on 2021-12-10. The firm is focused on the exploration and development of battery and precious metals. The firm has drill ready gold and nickel targets across five projects Laverton Western Australia and a further two gold projects in the Northern Territory. Its projects include battery metals projects and precious metals project. Its battery metals project includes Coglia project and Red Flag project. Its Precious Metals project include Burtville East prospect, Ironstone prospect, Annaburroo project, Marrakai project, 40-Mile Camp Prospect, Comet Well Prospect, and Mikado project. Coglia Nickel-Cobalt Project located around 70 kilometers (km) southeast of Laverton. The Red Flag is located in a prolific nickel-cobalt belt, 25 km west of Laverton. Burtville East is located within a 50 km radius of four gold mills. The Ironstone Project is located 50 km southeast of Laverton.
📈 Performance
Price History
-95.50%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.01
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in PNT
1
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
15 weeks
💵 Average investment amount
$3,144
⏰ Last time a customer invested in PNT
164 days
PNT investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
100%
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
100%
🙋 Legal gender of investors
Female
Male
100%
Pearlers who invest in PNT also invest in...
PMGOLD
PMGOLD.AX was created on 2003-05-09 by Perth Mint. The fund's investment portfolio concentrates primarily on gold commodities. PMGOLD.AX is designed to track the international price of gold in Australian dollars and offers investors a simple, low cost way to access the returns on gold.
🙌 Performance (5Yr p.a)
16.73%
📊 Share price
$50.95 AUD
📈 HIGH PRICE GROWTH
ETPMAG.AX was created on 2009-01-02 by Global X. The fund's investment portfolio concentrates primarily on silver commodities. ETFS Physical Silver (ETPMAG.AX) is designed to offer investors a simple, costefficient and secure way to access physical silver by providing a return equivalent to the movements in the silver spot price less the applicable management fee.
🙌 Performance (5Yr p.a)
12.36%
📊 Share price
$52.64 AUD
📈 HIGH PRICE GROWTH
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialization of immunotherapies against cancer. The company is headquartered in Sydney, New South Wales. The company is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs.
🙌 Performance (5Yr p.a)
67.72%
📊 Share price
$0.25 AUD
🧬 BIOTECHNOLOGY
Novatti Group Ltd. provides software technology and systems integration services. The company is headquartered in Melbourne, Victoria. The company went IPO on 2016-01-18. The Company’s solutions include issuing, acquiring, processing, and billing. Its segments include Payments AU and NZ, Payments International, and Technology Solutions. Payments AU/NZ segment include Payments Acquiring, Card Issuing, Cross Border Payments and Novatti Billpay. Payments International segment include ATX Payments (Malaysia) and Flexepin Payments (Europe). Technology Solutions include enterprise, automation and billing software. The company provides cash voucher services to a global customer base to enable cash to be transferred to a digital form for use on e-commerce trading and services Websites, with operations in Australia and Canada and pin-point solutions for other countries and regions. The company also offers Cross-border Payments provides wholesale payment facilitation in and out of Australia for its own affiliated agents.
🙌 Performance (5Yr p.a)
-16.98%
📊 Share price
$0.03 AUD
🤖 TECHNOLOGY
GDX.AX was created on 2015-06-26 by VanEck. The fund's investment portfolio concentrates primarily on materials equity. To achieve this investment objective, GDX.AX employs a passive management strategy of investing in the NYSE-listed GDX.AX issued and operated by VanEck in the United States.
🙌 Performance (5Yr p.a)
6.53%
📊 Share price
$80.18 AUD
🕊️ SOCIALLY AWARE
🧱 MATERIALS
⚖️ HIGH GOVERNANCE
Want more shares? Try these...
